Navigation Links
Fellowships for outstanding research in drug use and HIV awarded by IAS and NIDA
Date:7/12/2011

Wednesday July 13, 2011 (Geneva, Switzerland) -- The International AIDS Society (IAS) and the US National Institute on Drug Abuse (NIDA) today announced the recipients of their third annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance scientific understanding of the linkages between drug use and HIV while fostering multinational research.

Young researchers from China and Indonesia will be awarded post-doctoral fellowships to pursue outstanding research in the field. (1) IAS/NIDA research fellowships are awarded to junior scientists for 18 months for post-doctoral training and to well-established HIV researchers for eight months of professional development, both at institutes excelling in research on drug use and HIV.

Presentation of the IAS/NIDA fellowships will take place in a fortnight on Wednesday 20 July 2011 at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention at the Auditorium Parco della Musica in Rome, Italy.

The fellowships ceremony will take place immediately before the Plenary Session (08:45-11:00) where NIDA Director Dr Nora D Volkow will give a keynote presentation Ending HIV Transmission Among Drug Users by 2015.

"The innovative research projects that will be implemented by these talented scientists in different disciplines clinical science, law and public health cover multiple areas of research needed to improve strategies targeting HIV infections related to drug use," said IAS President Dr Elly Katabira.

Drug use is a global problem that brings with it greatly increased risk for HIV infection. Approximately three million of the estimated 15.9 million people aged 15 to 64 who injected drugs in 2008 are living with HIV. A total of 120 countries have reported cases of HIV among people who inject drugs. Injecting drug use represents one of the predominant modes of transmission of HIV in Eastern Europe and Central Asia, where HIV prevalence among people who inject drugs is higher than 40 per cent in some countries. Use of other drugs, such as cocaine and methamphetamine, even without injection, is also associated with increased HIV risk behaviours.

"If you don't treat drug dependency, the likelihood of an individual being infected by HIV becomes higher. We need to treat drug users if we want to treat HIV," said Dr Volkow. "In fact, preventing and treating drug use is treating HIV."

Drug-related HIV/AIDS epidemics have followed the spread of cocaine injecting in Latin America and heroin injecting in Asia in the 1980s and the massive spread of injecting heroin and other opiates in Eastern Europe in the 1990s.

Overall growth in numbers of new HIV infections has slowed in most regions of the world. One exception to this trend, however, is the continued growth in numbers of HIV infections linked to injecting drug use, especially in Eastern Europe, Central Asia and more recently, sub-Saharan Africa.


'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
International AIDS Society
Source:Eurekalert

Related medicine news :

1. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 12 top young scientists
3. University of Toronto scholars receive prestigious New Directions Fellowships
4. Anti-HIV gel leadership team acknowledged for outstanding achievement in world health
5. Outstanding high school students receive AGA Research Foundation Fellowship Awards
6. Outstanding quality of science at 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) underlines conference goal of translating HIV research into practice
7. AACR recognizes the outstanding achievements of Pier Paolo Pandolfi
8. ABTA names Ryan Salinas outstanding 10 summer medical student fellow
9. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
10. SWOG names 5 cancer researchers outstanding Young Investigators
11. SNM honors outstanding contributors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... received the CE Certificate of Conformity for the Smart System® 20/20. CE Certification ... the highest industry standards and specifications such as ANSI, ISO and proven test ...
(Date:3/27/2017)... ... March 27, 2017 , ... Advantexe Learning Solutions ... launch of a new research study, The Business Readiness Report. The report explores ... strategy, and the actual success of achieving individual and company goals. , ...
(Date:3/27/2017)... ... 2017 , ... According to the American Cancer Society , the average ... 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, the ... avoid this latter group, tune in to Lifestyle Magazine on April 9, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle ... 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of the facility. ... area-residents to celebrate two great years while also familiarizing themselves with the facility. ...
(Date:3/25/2017)... , ... March 25, 2017 , ... Getting earned media ... public relations partner. , All through the year, Garden Media aims to provide ... working with key influencers and pitching client’s key messages to gain coveted ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), ... address serious pulmonary diseases, today announced that it has added ... fibrosis and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the ... Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... Paul M. Bisaro as Impax,s President and ... Board, effective March 27, 2017. Mr. Bisaro will succeed ... Interim President and Chief Executive Officer since December of ... and branded pharmaceutical experience, Mr. Bisaro, 56, is an ...
Breaking Medicine Technology: